FDA warns pregnant and breast-feeding women to avoid CBD and cannabis products for fear of ‘serious risk’
By Elizabeth Crawford contact
17-Oct-2019 – Last updated on 06-Feb-2020 at 11:43 GMT
In an Oct. 16 Consumer Update, FDA acknowledges that “CBD-containing products are everywhere,” and that while “these products often make questionable health promises about CBD” the agency “has not approved these products,” other than a trio of prescription products containing either CBD or synthetic THC.
As such, it adds, “there may be serious risks to using cannabis products, including those containing CBD, if you are pregnant or breastfeeding.”
Specifically, the agency warns that “high doses of CBD in pregnant test animals have caused problems with the reproductive system of developing male fetuses,” and it expects that “some amount of CBD will be transferred to babies through breast milk.”
In addition, it warns it is investigating the “potential for CBD products to be contaminated with substances that may pose a risk to the fetus or breastfed baby, including THC” as well as pesticides, heavy metals, bacteria and fungus.
This research is part of a broader effort by FDA to understand the effects of CBD-containing products over a person’s entire life and in combination with each other. It also is examining the “the extent the presence of CBD in human milk harms the breastfed baby or the mother’s milk production.”
So far, it notes, “there are many unanswered questions about the science, safety and quality of products containing CBD during pregnancy and while breastfeeding,” and as such it encourages women to “not put yourself or your baby at risk by using cannabis products while pregnant or breastfeeding.”
FDA warned pregnant and breast-feeding women yesterday to avoid CBD, THC and marijuana in any form, including the proliferation of food, supplements and cosmetics containing CBD and other cannabis-derived ingredients that currently are flooding the market and making “questionable health promises.”